Document is current
Any future updates will be listed below
-
Authors
Barrett, Caroline M.
Long, Millie D.
Grimm, Ian
Herfarth, Hans H.
Barnes, Edward L.
- License Information
-
More Information
Article History
Accepted: 10 August 2022
First Online: 5 September 2022
Declarations
:
: Caroline M. Barrett and Ian Grimm have no relevant disclosures for this work. Hans H. Herfarth has served as a consultant for Alivio, AMAG, BMS, ExeGI, Finch, Janssen, Gilead, Lycera, Merck, Otsuka, Pfizer, PureTech, Seres and research support from Pfizer and Artizan Biosciences. Millie D. Long has served as a consultant for AbbVie, UCB, Takeda, Janssen, Pfizer, Salix, Valeant, Target Pharmasolutions and has received research support from Pfizer and Takeda. Edward L. Barnes has served as a consultant for AbbVie, Takeda, and Target Pharmasolutions.
